The deal size was increased to $175M in common stock from $150M in common stock and priced at the low-end of the $10.00-$10.25 range. Goldman Sachs, Morgan Stanley, Cowen and Allen & Co. acted as joint book running managers for the offering.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PACB:
- Pacific Biosciences $150M Spot Secondary; price range $10.00-$10.25
- Pacific Biosciences announces $150M common stock offering
- Pacific Biosciences downgraded to Neutral at Cantor Fitzgerald on valuation
- Pacific Biosciences downgraded to Neutral from Overweight at Cantor Fitzgerald
- Pacific Biosciences partners with University of Tokyo
